BTOG-2 Trial 

A British Thoracic Oncology Group phase III trial of gemcitabine plus cisplatin at 80mg/m2 versus gemcitabine plus cisplatin at 50 mg/m2 versus gemcitabine plus carboplatin AUC 6 in stage IIIB/IV non-small cell lung cancer.

EUDRACT: 2004-003868-30

Status Actively recruiting

Estimated end of recruitment phase September 2010

The study is run from the Institute for Cancer Studies at the University of Birmingham who are the co-sponsors together with Royal Wolverhampton Hospitals NHS Trust.For general enquiries about the trial or website or to gain access to trial documents on the web please e-mail

BTOG 2 logo with stretched lettering and some lungs as the backdrop.